Eclipse Bioinnovations
Eclipse Bioinnovations: A San Diego-based biotech start-up, innovating in genomics and next-gen sequencing.
Founded
2017Eclipse Bioinnovations: A San Diego-based biotech start-up, innovating in genomics and next-gen sequencing.
Eclipse Bioinnovations, founded in San Diego, is a biotechnology startup dedicated to advancing genomics through next-generation sequencing technologies. The company’s core mission is to develop innovative products and services that profile RNA binding protein interactions and other RNA mechanisms. Their offerings include specialized sequencing services such as RBP-eCLIP™, miR-eCLIP™, m6A-eCLIP™, and eRibo Pro™, which cater to researchers studying RNA-protein interactions, miRNA-mRNA interactions, and RNA modifications.
Notable figures associated with Eclipse Bioinnovations include experts in genomics and biotechnology, though specific names are not publicly highlighted. The company has made significant strides in the field of RNA genomics, contributing valuable data and tools to the scientific community. Their technologies have been adopted by leading research institutions, underscoring their impact on advancing RNA research and understanding complex biological processes.
Companies similar to Eclipse Bioinnovations include RealSeq Biosciences, Element Biosciences, Jumpcode Genomics and Alida Biosciences.
Eclipse Bioinnovations was founded in 2017.
Eclipse Bioinnovations' headquarters is located in San Diego, CA, US.
Eclipse Bioinnovations' most recent funding round was for $14M (USD) in March 2022.
As of Mar 15, 2022, Eclipse Bioinnovations has disclosed funding of $26M (USD). Undisclosed round amounts are excluded.
Eclipse Bioinnovations has 45 employees as of Feb 5, 2024.
alidabio.com
